
Neurologist

No OPD information available
Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
Primary Lateral Sclerosis
Frontotemporal Dementia
Cramp-Fasciculation Syndrome
Dementia
Gastrostomy
Movement Disorders
Neuronal Intranuclear Inclusion Disease (NIID)
Parkinson's Disease
Spinocerebellar Ataxia Type 8
Tongue Cancer
Dominic B. Rowe is a male medical professional who helps patients with various conditions like Amyotrophic Lateral Sclerosis (ALS), Primary Lateral Sclerosis, and Frontotemporal Dementia. He also treats Cramp-Fasciculation Syndrome, Dementia, Gastrostomy, Movement Disorders, Neuronal Intranuclear Inclusion Disease (NIID), Parkinson's Disease, Spinocerebellar Ataxia Type 8, and Tongue Cancer.
Dominic B. Rowe uses special skills and treatments to care for his patients. He communicates effectively with patients, which helps them trust him. Patients appreciate his knowledge and expertise in treating their conditions.
To stay updated with the latest medical knowledge, Dominic B. Rowe regularly reads research articles and attends conferences. He values learning and improving his skills to provide the best care for his patients.
Dominic B. Rowe works well with his colleagues and other medical professionals. He believes in teamwork and collaboration to ensure the best outcomes for his patients. His positive relationships with others in the medical field contribute to his success in treating patients.
Dominic B. Rowe's work has had a positive impact on many patients' lives. His dedication and expertise have helped improve the health and well-being of those he treats. Patients often express gratitude for the care and support they receive from him.
One of Dominic B. Rowe's notable publications is titled "Polysomnographic titration of non-invasive ventilation in motor neurone disease (3TLA): study protocol for a randomised controlled trial," published in Trials in August 13, 2024. He is also involved in a clinical trial called "A Phase 2a Open-Label Preliminary Safety, Efficacy, and Biomarker Study of WP-0512 in Patients With Amyotrophic Lateral Sclerosis (ALS)," which is currently active but not recruiting participants.
Overall, Dominic B. Rowe is a dedicated and skilled medical professional who is committed to providing excellent care for his patients and advancing medical knowledge in his field.
Enrollment Status: Active not recruiting
Published: April 08, 2025
Intervention Type: Drug
Study Drug: Fasudil (WP-0512)
Study Phase: Phase 2
